Abstract:Three new complexes (1-3) have been synthesized and characterized by X-ray single crystal determination and evaluated for inhibitory activity on jack bean urease. All the complexes contained a new cinnamic acid derivative as the ligand (C11H12O4), (E)-3-(3,4-dimethoxyphenyl)acrylic acid, and crystallized in monoclinic C2/c space group. Complex 1 (C11H11O4)(4)(C3N2H8)(2)Cu-2 (C3N2H8=1,2-diaminopropane) was obtained with a=20.488(2), b=19.596(2), c=15.2500(13), beta=93.502(2)degrees, V=6111.2(10)angstrom(3), Z=4, R-1=0.0616, and wR(2)=0.2059. Complex 2 (C11H11O4)(4)(C3N2H8)(2)Cu-2 (C3N2H8=1,3-diaminopropane) was obtained with a=20.2494(12), b=19.5732(12), c=14.8940(8), beta=96.884(2)degrees, V=5860.6(6)angstrom(3), Z=4, R-1=0.0409, and wR(2)=0.1107. Complex 3 (C11H11O4)(2)(C2N2H6)(2)Ni2 center dot H2O (C2N2H6=ethylenediamine) was obtained with a=28.359(2), b=6.5422(5), c=16.8587(14), beta=101.359(2)degrees, V=3066.5(4)angstrom(3), Z=4, R-1=0.0422, and wR(2)=0.1190. It was found that copper(II) complexes 1 [IC50=4.71 mu M] and 2 [IC50=3.15M] showed strong inhibitory activity against jack bean urease compared with acetohydroxamic acid [IC50=10.01 mu M] as a positive reference. Unfortunately, 3 exhibited no inhibitory activity.

Synthesis and Biological Evaluation of Cu(Ii), Zn(Ii), and Ni(Ii) 3-(4-nitrophenyl)acrylic Acid Complexes with Diamines As Potential Urease Inhibitors

Synthesis, structure, and biological evaluation of three Cu(II) and Ni(II) (E)-3-(3,4-dimethoxyphenyl)acrylate complexes with organic diamines as potential urease inhibitors

Synthesis, Crystal Structures, Molecular Docking and Urease Inhibitory Activity of Nickel(ii) Complexes with 3-Pyridinyl-4-amino-5-mercapto-1,2,4-triazole

Synthesis, Structure, and Urease Inhibitory Activities of Three Binuclear Copper(ii) Complexes with Protocatechuic Acid Derivative

Synthesis, Structures and Urease Inhibition Studies of Copper(ii) and Nickel(ii) Complexes with Bidentate N,O-donor Schiff Base Ligands.

Transition Metal Complexes (m=cu, Ni and Mn) of Schiff-base Ligands: Syntheses, Crystal Structures, and Inhibitory Bioactivities Against Urease and Xanthine Oxidase

Synthesis, Molecular Docking and Biological Evaluation of Schiff Base Transition Metal Complexes As Potential Urease Inhibitors

Synthesis, Crystal Structures, Molecular Docking, and in Vitro Biological Activities Evaluation of Transition Metal Complexes with 4-(3,4-dichlorophenyl) Piperazine-1-Carboxylic Acid

Synthesis, Crystal Structure, and Urease Inhibition Studies of Copper(Ii) and Cobalt(Iii) Complexes with Bi(2-Fluorobenzylaminoethyl)Amine

Synthesis, Structure, and Urease Inhibitory Activities of Co(Iii), Mn(Ii) and Zn(Ii) Complexes with Hydrazone Derived from Protocatechuic Acid

Syntheses, Characterization and Crystal Structures of Dicyanamide Bridged Polynuclear Copper(II) and Zinc(II) Complexes with Urease Inhibitory Activity

Synthesis, Characterization and Crystal Structures of Schiff Base Copper Complexes with Urease Inhibitory Activity

Synthesis, Structure, Urease Inhibitory, and Cytotoxic Activities of Two Complexes with Protocatechuic Acid Derivative and Phenanthroline

New Method for the Synthesis of A Mononucleating Cyclic Peptide Ligand, Crystal Structures of Its Ni, Zn, Cu, and Co Complexes, and Their Inhibitory Bioactivity Against Urease

Synthesis, Crystal Structure and Urease Inhibitory Activities of Schiff Base Metal Complexes

Synthesis, Molecular Docking, and Inhibitory Activity of a Ni Schiff-base Complex Against Urease

Synthesis, Evaluation and Mechanism Exploration of 2-(N-(3-nitrophenyl)-n-phenylsulfonyl)aminoacetohydroxamic Acids As Novel Urease Inhibitors.

Structure and Urease Inhibitory Activity of Copper(ii) Complex with ( E )-3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)acrylic Acid

Syntheses, Structures and Urease Inhibitory Activities of Mononuclear Cobalt(iii) and 1D Cobalt(ii) Complexes with Ligands Derived from 3-Formylsalicylic Acid

Synthesis, Inhibitory Activity and Molecular Docking Studies of Two Cu(II) Complexes Against Helicobacter Pylori Urease.

Preparations, Characterization, and Biological Features of Mononuclear Cu(II) Complexes Based on Hydrazone Ligands.